Abstract:Abstract CRSIPR-Cas9 system has opened up the avenue to efficient genome editing 1–4 . However, together with known off-target effects, several concerns of current CRISPR-Cas9 platform, including severe DNA damage, cytotoxicity, and large genomic alteration, have emerged in recent reports 5–7 and establish a formidable obstacle to precisely model allele dosage effects of disease mutations and risk variants, especially mono-allelic effects, and correct them. Here, by developing an allele-specific indel monitor system (AIMS), we demonstrate that small and simple modification of conventional single-guide RNAs (sgRNAs) enable programmable tuning of CRISPR-Cas9 activities and alleviate such adverse effects. AIMS, which visualizes various indel events in two alleles separately in living cells, is convenient and accurate to determine the in vitro editing efficiency and revealed frequent mosaicism during genome editing. Using AIMS, we show that adding cytosine stretches to the 5’ end of conventional sgRNA efficiently reduced Cas9 activity in a length dependent manner. By combining systematic experiments and computational modeling, we established the quantitative relationships between the length of cytosine extension and multiple aspects of CRISPR-Cas9 system. In general, short cytosine extension dramatically relieves p53-dependent cytotoxicity and suppression of homology-directed repair (HDR) while relatively maintaining on-target activity. Long cytosine extension further decreases on-target activity, thereby maximizing mono-allelic editing, while conventional system typically induces bi-allelic editing. Furthermore, such downregulation of on-target activity contributes to downregulation of relative off-target activity and protection of HDR-allele from second off-target editing. Therefore, cytosine extension method finally enables both single-step generation of heterozygous single-nucleotide disease mutations from homozygous states in mouse ES cells and correction of heterozygous disease mutations in human iPS cells. Taken together, our study proposes updates of standard CRISPR-Cas9 platform in mammalian cells toward precise and safe genome editing in diverse applications.

Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage

[Optimization of CRISPR/Cas9-based multiplex base editing in Corynebacterium glutamicum].

Targeted Mutagenesis of Duplicated Genes in Caenorhabditis Elegans Using CRISPR-Cas9

Search-and-replace Editing of Genetic Information

Programmable DNA Repair with CRISPRa/i Enhanced Homology-Directed Repair Efficiency with a Single Cas9

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Base editing: precision chemistry on the genome and transcriptome of living cells

Programmable RNA base editing via targeted modifications

Two Compact Cas9 Ortholog-Based Cytosine Base Editors Expand the DNA Targeting Scope and Applications In Vitro and In Vivo

Expanding the Genome-Targeting Scope and the Site Selectivity of High-Precision Base Editors

Highly Efficient Base Editing in Bacteria Using a Cas9-cytidine Deaminase Fusion

An in situ cut-and-paste genome editing platform mediated by CRISPR/Cas9 or Cas12a

Deaminase-mediated multiplex genome editing in Escherichia coli

Expanding the editable genome and CRISPR–Cas9 versatility using DNA cutting-free gene targeting based on in trans paired nicking

Base Editing with a Cpf1–cytidine Deaminase Fusion

Precision genome editing using synthesis-dependent repair of Cas9-induced DNA breaks

An <i>in situ</i> cut-and-paste genome editing platform mediated by CRISPR/Cas9 or Cas12a

Programmable downsizing of CRISPR-Cas9 activity for precise and safe genome editing

An APOBEC3A-Cas9 Base Editor with Minimized Bystander and Off-Target Activities

Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity

Efficient C-to-G Base Editing with Improved Target Compatibility Using Engineered Deaminase-nCas9 Fusions.